To test this hypothesis, we initially examined the protein expression levels of NF‐κB p65 and phosphorylated NF‐κB p65 (p‐NF‐κB p65) with CRYAB knockdown or overexpression in gastric cancer cells. This evidence concerns the gene NFKB1 and gastric cancer.